TTI-101 oral / StemMed, Tvardi Therap 
Welcome,         Profile    Billing    Logout  

6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
TTI-101 oral / Tvardi Therap
NCT05671835: Study of TTI-101 in Participants With Idiopathic Pulmonary Fibrosis

Recruiting
2
100
US
TTI-101, Placebo
Tvardi Therapeutics, Incorporated
Idiopathic Pulmonary Fibrosis
03/25
03/25
NCT06141031: Trial of Radiotherapy in Combination With TTI-101 in Patients With Borderline Resectable Pancreatic Cancer

Recruiting
1/2
35
US
TTI-101
University of Colorado, Denver, Tvardi Therapeutics, Incorporated
Pancreatic Cancer
09/27
09/28
REVERT, NCT05384119: Phase 1b/2 Study of TTI-101 in Combination for Patients With Metastatic Hormone Receptor-Positive and HER2-Negative Breast Cancer

Completed
1/2
6
US
TTI-101, Palbociclib, Ibrance ®, Aromatase inhibitor (AI), fulvestrant, ribociclib
Tvardi Therapeutics, Incorporated
Breast Cancer
04/24
04/24
NCT05440708: A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma

Recruiting
1/2
166
US
TTI-101, Pembrolizumab, Keytruda®, Atezolizumab, Tecentriq®, Bevacizumab, Avastin®
Tvardi Therapeutics, Incorporated
Hepatocellular Carcinoma
03/25
03/25
NCT03195699: Oral STAT3 Inhibitor, TTI-101, in Patients With Advanced Cancers

Active, not recruiting
1
60
US
TTI-101
Tvardi Therapeutics, Incorporated, M.D. Anderson Cancer Center
Breast Cancer, Head and Neck Squamous Cell Carcinoma, Non Small Cell Lung Cancer, Hepatocellular Cancer, Colorectal Cancer, Gastric Adenocarcinoma, Melanoma, Advanced Cancer
12/24
12/24
NCT05845307: Randomized Pre-surgical Window-of-Opportunity Trial of TTI-101 in Patients With Stage II-IV Resectable HPV-negative Squamous Cell Carcinoma of the Head and Neck

Not yet recruiting
1
33
US
Control Group, TTI-101
M.D. Anderson Cancer Center, Tvardi Therapeutics, Inc, National Institutes of Health (NIH)
Squamous Cell Carcinoma of Head and Neck
02/25
02/25

Download Options